RC
Ra Capital Management, L.P. disclosed a 33% stake in CLYM
Ra Capital Management, L.P. reported owning 33% of Climb Bio, Inc. (CLYM) (23,941,277 shares) in a Schedule 13D filed Nov 9, 2026.
A 13D means the holder may push for changes at the company.